EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+59.14%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$605M
AUM Growth
+$605M
(+59%)
Cap. Flow
+$75.6M
Cap. Flow
% of AUM
12.49%
Top 10 Holdings %
Top 10 Hldgs %
55.57%
Holding
81
New
22
Increased
20
Reduced
20
Closed
14
Top Buys
Top Sells
| 1 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$31M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$27.2M |
| 3 |
Danaher
DHR
|
$22.3M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$15.6M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$12.8M |
Sector Composition
| 1 | Healthcare | 96.24% |
| 2 | Communication Services | 1.96% |
| 3 | Financials | 0% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXFD
26
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.55M | 0.62% | 350,138 +177,945 | +103% | +$2.31M |
|
|
AFMD
27
DELISTED
Affimed
AFMD
| $4.35M | 0.6% | 942,989 +382,189 | +68% | +$1.76M |
|
28
Amneal Pharmaceuticals
AMRX
$3B
| $4.22M | 0.58% | +886,587 | New | +$4.22M |
|
|
AUTL
29
Autolus Therapeutics
AUTL
$399M
| $4.14M | 0.57% | 258,360 +48,347 | +23% | +$775K |
|
|
MNTA
30
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $4.14M | 0.57% | 124,338 -22,212 | -15% | -$739K |
|
31
Qiagen
QGEN
$10.1B
| $3.53M | 0.48% | +82,466 | New | +$3.53M |
|
32
Cytokinetics
CYTK
$4.23B
| $3.34M | 0.46% | 141,700 -40,000 | -22% | -$943K |
|
|
DRNA
33
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $3.27M | 0.45% | 128,905 +69,131 | +116% | +$1.76M |
|
|
RDUS
34
DELISTED
Radius Health, Inc.
RDUS
| $3M | 0.41% | 220,110 -80,963 | -27% | -$1.1M |
|
35
HCA Healthcare
HCA
$94.5B
| $2.95M | 0.4% | 30,400 -70,600 | -70% | -$6.85M |
|
|
VAPO
36
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $2.94M | 0.4% | +71,819 | New | +$2.94M |
|
37
DexCom
DXCM
$29.5B
| $2.7M | 0.37% | 6,670 -12,867 | -66% | -$5.22M |
|
|
BDSI
38
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $2.54M | 0.35% | 583,504 +460,802 | +376% | +$2.01M |
|
39
Sanofi
SNY
$121B
| $2.54M | 0.35% | 49,778 -139,800 | -74% | -$7.14M |
|
|
CCXI
40
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.35M | 0.32% | 40,842 -539,169 | -93% | -$31M |
|
|
CNCE
41
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2.32M | 0.32% | +232,983 | New | +$2.32M |
|
42
Pennant Group
PNTG
$830M
| $2.32M | 0.32% | 102,568 -179,613 | -64% | -$4.06M |
|
|
OTIC
43
DELISTED
Otonomy, Inc.
OTIC
| $2.18M | 0.3% | 601,163 +39,426 | +7% | +$143K |
|
44
Kiniksa Pharmaceuticals
KNSA
$2.48B
| $2.08M | 0.29% | +81,700 | New | +$2.08M |
|
|
ALBO
45
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $2.07M | 0.28% | 78,029 | – | – |
|
46
Standard BioTools
LAB
$481M
| $1.88M | 0.26% | +467,923 | New | +$1.88M |
|
47
scPharmaceuticals
SCPH
$295M
| $1.82M | 0.25% | 247,419 +115,000 | +87% | +$846K |
|
48
Prothena Corp
PRTA
$441M
| $1.59M | 0.22% | +152,213 | New | +$1.59M |
|
49
Community Health Systems
CYH
$387M
| $1.48M | 0.2% | 492,272 -88,078 | -15% | -$265K |
|
50
Cyclerion Therapeutics
CYCN
$7.91M
| $1.46M | 0.2% | 247,663 -89,482 | -27% | -$529K |
|